Regeneron Announces Agreement with U.S. Government to Help Lower Drug Costs for American Patients and Will Provide Innovative New Gene Therapy for Free in the U.S.
Go back to Regeneron Announces Agreement with U.S. Government to Help Lower Drug Costs for American Patients and Will Provide Innovative New Gene Therapy for Free in the U.S.| Regeneron (NASDAQ: REGN) | Delayed: 612.50 +2.56 (0.42%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $609.94 | 52 Week High | $592.36 | |||
| Open | $604.46 | 52 Week Low | $325.35 | |||
| Day High | $613.56 | P/E | 160.76 | |||
| Day Low | $594.90 | EPS | $3.81 | |||
| Volume | 1,604,280 | |||||
